Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why does remyelination fail in multiple sclerosis?

Robin J M Franklin1

  • 1Department of Clinical Veterinary Medicine and Cambridge Centre for Brain Repair, University of Cambridge, Madingley Road, Cambridge CB3 0ES, UK. rjf1000@cam.ac.uk

Nature Reviews. Neuroscience
|September 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging progenitor cell differentiation during central nervous system remyelination using an MRI gene reporter.

Brain : a journal of neurology·2026
Same author

Platelets regulate neural and oligodendroglial progenitors when infiltrating the brain parenchyma.

Communications biology·2025
Same author

Impaired maturation and differentiation of oligodendrocytes in the vacuole formation myelin mutant rat.

Veterinary pathology·2025
Same author

Ageing and remyelination failure in people with multiple sclerosis.

Brain : a journal of neurology·2025
Same author

Imaging progenitor cell differentiation during central nervous system remyelination using an MRI gene reporter.

bioRxiv : the preprint server for biology·2025
Same author

Metformin alters mitochondria-related metabolism and enhances human oligodendrocyte function.

Nature communications·2025
Same journal

Brain-spleen axis regulates learned fear.

Nature reviews. Neuroscience·2026
Same journal

Acetylcholine: a candidate substrate for hippocampal predictive learning?

Nature reviews. Neuroscience·2026
Same journal

Astrocytes viewed through the lens of their proteomes and subproteomes.

Nature reviews. Neuroscience·2026
Same journal

m<sup>6</sup>A in RNA: a key regulator of brain development, function and disease.

Nature reviews. Neuroscience·2026
Same journal

Non-invasive deep-brain neuromodulation by transcranial radio frequency stimulation.

Nature reviews. Neuroscience·2026
Same journal

Heading into the wild: setting the course to natural neuroscience.

Nature reviews. Neuroscience·2026
See all related articles

Multiple sclerosis causes neurological disability, with failed remyelination hindering recovery. Understanding this failure is key to developing new treatments for multiple sclerosis patients.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Multiple sclerosis (MS) is a leading cause of neurological disability in young adults.
  • MS is characterized by a complex, multifactorial etiology and heterogeneous pathology, making diagnosis and treatment challenging.
  • A critical issue in MS is the inadequate remyelination, a regenerative process that fails as the disease progresses, leading to increased clinical deterioration.

Purpose of the Study:

  • To understand the reasons behind the failure of remyelination in multiple sclerosis.
  • To identify factors contributing to persistent demyelination in MS lesions.
  • To provide insights for developing strategies to enhance remyelination in MS.

Main Methods:

  • This study focuses on understanding the biological mechanisms underlying remyelination failure in multiple sclerosis.

Related Experiment Videos

  • The research examines the differences between efficient remyelination in experimental models and the impaired repair observed in progressive MS.
  • Analysis involves investigating the cellular and molecular factors that impede the remyelination process within demyelinated lesions.

    • Main Results:

    • While remyelination is efficient in experimental models, it is often incomplete or absent in established multiple sclerosis lesions.
    • The persistence of demyelination in a growing number of lesions correlates significantly with clinical decline in MS patients.
    • Factors contributing to the failure of oligodendrocyte precursor cell differentiation and myelin sheath formation in the MS central nervous system are under investigation.

    Conclusions:

    • The failure of remyelination is a major contributor to the progressive neurological disability seen in multiple sclerosis.
    • Further research into the barriers of remyelination is essential for therapeutic development.
    • Enhancing the natural remyelination process holds significant potential for improving outcomes in multiple sclerosis.